AP3B1 Has Type I Interferon-Independent Antiviral Function against SARS-CoV-2
G. Mani Subramanian(National Institutes of Health), Sonja M. Best(National Institutes of Health)
Cited by 2
Related Papers
Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19
|Nature Communications|2023|24
TRIM5α restricts flavivirus replication by targeting the viral protease for proteasomal degradation
|bioRxiv (Cold Spring Harbor Laboratory)|2019|2
Mitophagy antagonism by Zika virus reveals Ajuba as a regulator of PINK1-Parkin signaling, PKR-dependent inflammation, and viral invasion of tissues
|bioRxiv (Cold Spring Harbor Laboratory)|2021|2
Restraint of Powassan virus replication by TRIM5α facilitates viral avoidance of antiviral immunity
|bioRxiv (Cold Spring Harbor Laboratory)|2026|0